These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
661 related articles for article (PubMed ID: 30903363)
21. Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer. Rozengurt E; Sinnett-Smith J; Kisfalvi K Clin Cancer Res; 2010 May; 16(9):2505-11. PubMed ID: 20388847 [TBL] [Abstract][Full Text] [Related]
22. Metformin and cancer: Between the bioenergetic disturbances and the antifolate activity. Jara JA; López-Muñoz R Pharmacol Res; 2015 Nov; 101():102-8. PubMed ID: 26277279 [TBL] [Abstract][Full Text] [Related]
23. Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer. Athreya AP; Kalari KR; Cairns J; Gaglio AJ; Wills QF; Niu N; Weinshilboum R; Iyer RK; Wang L Oncotarget; 2017 Apr; 8(16):27199-27215. PubMed ID: 28423712 [TBL] [Abstract][Full Text] [Related]
24. Metformin promotes mitophagy in mononuclear cells: a potential in vitro model for unraveling metformin's mechanism of action. Bhansali S; Bhansali A; Dhawan V Ann N Y Acad Sci; 2020 Mar; 1463(1):23-36. PubMed ID: 31225649 [TBL] [Abstract][Full Text] [Related]
25. Metformin and energy metabolism in breast cancer: from insulin physiology to tumour-initiating stem cells. Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Martin-Castillo B; Menendez JA Curr Mol Med; 2010 Oct; 10(7):674-91. PubMed ID: 20712585 [TBL] [Abstract][Full Text] [Related]
26. Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation. Li DJ; Huang F; Lu WJ; Jiang GJ; Deng YP; Shen FM Acta Physiol (Oxf); 2015 Mar; 213(3):711-21. PubMed ID: 25382002 [TBL] [Abstract][Full Text] [Related]
27. Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial. Hadad S; Iwamoto T; Jordan L; Purdie C; Bray S; Baker L; Jellema G; Deharo S; Hardie DG; Pusztai L; Moulder-Thompson S; Dewar JA; Thompson AM Breast Cancer Res Treat; 2011 Aug; 128(3):783-94. PubMed ID: 21655990 [TBL] [Abstract][Full Text] [Related]
28. Metformin is synthetically lethal with glucose withdrawal in cancer cells. Menendez JA; Oliveras-Ferraros C; Cufí S; Corominas-Faja B; Joven J; Martin-Castillo B; Vazquez-Martin A Cell Cycle; 2012 Aug; 11(15):2782-92. PubMed ID: 22809961 [TBL] [Abstract][Full Text] [Related]
29. Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy. Eisenreich A; Leppert U Curr Med Chem; 2017; 24(31):3397-3412. PubMed ID: 28393693 [TBL] [Abstract][Full Text] [Related]
30. Anti-tumour effect of metformin in canine mammary gland tumour cells. Saeki K; Watanabe M; Tsuboi M; Sugano S; Yoshitake R; Tanaka Y; Ong SM; Saito T; Matsumoto K; Fujita N; Nishimura R; Nakagawa T Vet J; 2015 Aug; 205(2):297-304. PubMed ID: 25981932 [TBL] [Abstract][Full Text] [Related]
31. Neuro-Protective Role of Metformin in Patients with Acute Stroke and Type 2 Diabetes Mellitus via AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Pathway and Oxidative Stress. Zhao M; Li XW; Chen Z; Hao F; Tao SX; Yu HY; Cheng R; Liu H Med Sci Monit; 2019 Mar; 25():2186-2194. PubMed ID: 30905926 [TBL] [Abstract][Full Text] [Related]
32. Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells. Lee SK; Lee JO; Kim JH; Kim SJ; You GY; Moon JW; Jung JH; Park SH; Uhm KO; Park JM; Suh PG; Kim HS J Cell Biochem; 2011 May; 112(5):1259-67. PubMed ID: 21465524 [TBL] [Abstract][Full Text] [Related]
33. Current understanding of metformin effect on the control of hyperglycemia in diabetes. An H; He L J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209 [TBL] [Abstract][Full Text] [Related]
34. Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation. Vara-Ciruelos D; Dandapani M; Russell FM; Grzes KM; Atrih A; Foretz M; Viollet B; Lamont DJ; Cantrell DA; Hardie DG Cell Rep; 2019 Apr; 27(3):690-698.e4. PubMed ID: 30995468 [TBL] [Abstract][Full Text] [Related]
35. LKB1/AMPK inhibits TGF-β1 production and the TGF-β signaling pathway in breast cancer cells. Li NS; Zou JR; Lin H; Ke R; He XL; Xiao L; Huang D; Luo L; Lv N; Luo Z Tumour Biol; 2016 Jun; 37(6):8249-58. PubMed ID: 26718214 [TBL] [Abstract][Full Text] [Related]
36. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer. Guppy A; Jamal-Hanjani M; Pickering L Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836 [TBL] [Abstract][Full Text] [Related]
37. Metformin: its emerging role in oncology. Micic D; Cvijovic G; Trajkovic V; Duntas LH; Polovina S Hormones (Athens); 2011; 10(1):5-15. PubMed ID: 21349801 [TBL] [Abstract][Full Text] [Related]
38. Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target. Boyle JG; Salt IP; McKay GA Diabet Med; 2010 Oct; 27(10):1097-106. PubMed ID: 20854376 [TBL] [Abstract][Full Text] [Related]
39. Role of AMP-activated protein kinase in mechanism of metformin action. Zhou G; Myers R; Li Y; Chen Y; Shen X; Fenyk-Melody J; Wu M; Ventre J; Doebber T; Fujii N; Musi N; Hirshman MF; Goodyear LJ; Moller DE J Clin Invest; 2001 Oct; 108(8):1167-74. PubMed ID: 11602624 [TBL] [Abstract][Full Text] [Related]
40. Metformin - its potential anti-cancer and anti-aging effects. Podhorecka M; Ibanez B; Dmoszyńska A Postepy Hig Med Dosw (Online); 2017 Mar; 71(0):170-175. PubMed ID: 28258677 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]